(3R,8R,9S,10R,13S,14S,17R)-17-[2-(Butylamino)-1,3-thiazol-4-yl]-10,13-dimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol dihydrate

(3R,8R,9S,10R,13S,14S,17R)-17-[2-(Butylamino)-1,3-thiazol-4-yl]-10,13-dimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol dihydrate Struktur
101915-06-4
CAS-Nr.
101915-06-4
Englisch Name:
(3R,8R,9S,10R,13S,14S,17R)-17-[2-(Butylamino)-1,3-thiazol-4-yl]-10,13-dimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol dihydrate
Synonyma:
(3R,8R,9S,10R,13S,14S,17R)-17-[2-(Butylamino)-1,3-thiazol-4-yl]-10,13-dimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol dihydrate
CBNumber:
CB714377502
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

(3R,8R,9S,10R,13S,14S,17R)-17-[2-(Butylamino)-1,3-thiazol-4-yl]-10,13-dimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol dihydrate Eigenschaften

Sicherheit

(3R,8R,9S,10R,13S,14S,17R)-17-[2-(Butylamino)-1,3-thiazol-4-yl]-10,13-dimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol dihydrate Chemische Eigenschaften,Einsatz,Produktion Methoden

(3R,8R,9S,10R,13S,14S,17R)-17-[2-(Butylamino)-1,3-thiazol-4-yl]-10,13-dimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol dihydrate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(3R,8R,9S,10R,13S,14S,17R)-17-[2-(Butylamino)-1,3-thiazol-4-yl]-10,13-dimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol dihydrate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alfa Chemistry

Info@alfa-chemistry.com United States 24072 58

  • (3R,8R,9S,10R,13S,14S,17R)-17-[2-(Butylamino)-1,3-thiazol-4-yl]-10,13-dimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-diol dihydrate
  • 101915-06-4
Copyright 2019 © ChemicalBook. All rights reserved